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A case of possible genetic predisposition to myelodysplastic syndrome
Um caso de possível predisposição genética à síndrome mielodisplástica
any of the simple modes of inheritance.
Genomic paternal imprinting phenomenon may play
an important role in the MDS origin in these cases.3
Rearrangements of 11q23 and 21q22, usually
involving MLL and AML1 genes, have been described in
de novo and secondary MDS,4 but coexisting abnormalities
of 11q23 and 21q22 are rare in MDS. 4
Herein, we showed with an educational purpose, the
image obtained from the karyotype of one MDS patient
with t(11;21)(q13;q22) seen in our service, whose father,
who did not suffer from any haematological disease,
presented the same chromosomal abnormality.
The patient, a 20-year-old woman, was referred to
hospital in May 1999 due to anaemia. No history of cytotoxic
or genotoxic exposure could be obtained. Muco-cutaneous
pallor was the only abnormality present at physical
examination. Blood count showed: RBC: 3.2 x106/ul, HGB:
10.2g/dl, HCT: 29.9%, MCV: 93.0fl, MCH: 33.3pg, MCHC:
35.8g/dl, RDW: 14.3%, Retic: 3.2x106/ul, WBC: 7.3x103/ul,
neutrophil: 2.9x103/ul, lymphocyte: 3.7x103/ul, PLT:
344.0x103/ul. Serum ferritin, folic acid, cobalamin, bilirrubin,
haptoglobin, urea, creatinine, thyroid hormones, were
normal. Immunological diseases were excluded by specific
evaluations. Sorological tests for the virus of hepatitis B,
C and HIV were negative. Bone marrow aspirate and
biopsy showed pronounced hypercellularity with atypias
in erythroblasts and granulocytes. Nor ringed sideroblasts
neither increase in myeloblast count were seen. The
karyoptype shows the t(11;21)(q13;q22) (Figure 1). The
diagnosis of MDS of refractory anaemia type was
established.
The same chromosomal abonormality was found in
her father, a 58 years old health man (Figure 2). Her mother's
karyoype was normal. Genomic paternal imprinting on
chromosome 11 may have played an important role in the
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Myelodysplastic syndrome (MDS) is uncommon in
young people1 and approximately one-third of these ca-
ses seem to result from a genetic predisposition, usually
involving the chromosomes 7 and 8.2 As only some
members of the family with the chromosomal abnormality
may present MDS, it is not easy to explain the disease by
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origin of the patient's disease, as this kind of phenomenon
has not yet been described on chromosome 21.
Evaluations of methylation status of the chromosome
11 and molecular analyses of the MLL and AML genes
would be performed in the patient and her father, but she
abandoned the medical service after six months of follow
up and no additional peripheral or bone marrow samples of
either individual were available at this time.
Therefore, we can only suggest that the patient´s
disease was determined for the inherited translocation,
but no consistent conclusions about this matter could be
obtained by our group.
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Fig. 1 –  G-banded karyotype obtained from the myelodysplastic
syndrome patient at diagnosis: 46, XX, t(11;21)(q13;q22). The
arrows show the chromosomal abnormalities
Fig. 2 – G-banded karyotype obtained from the father´s
myelodysplastic syndrome patient: 46, XY, t(11;21)(q13;q22).
The arrows show the chromosomal abnormalities
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